Search Ontology:
ChEBI
delavirdine
- Term ID
- CHEBI:119573
- Synonyms
-
- (N-[2-[4-[3-(1-methylethylamino)pyridin-2-yl]piperazin-1-yl]carbonyl-1H-indol-5-yl] methanesulfonamide)
- 1-(3-((1-methylethyl)amino)-2-pyridinyl)-4-((5-((methylsulfonyl)amino)-1H-indol-2-yl)carbonyl)piperazine
- 2-(4-(5-methanesulfonamido-1H-indol-2-ylcarbonyl)-1-piperazinyl)-N-(1-methylethyl)-3-pyridinamine
- Delavirdine
- N-(2-(1-(3-(isopropylamino)pyridin-2-yl)piperazine-4-carbonyl)-1H-indol-5-yl)methanesulfonamide
- N-[2-({4-[3-(propan-2-ylamino)pyridin-2-yl]piperazin-1-yl}carbonyl)-1H-indol-5-yl]methanesulfonamide
- N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide
- Definition
- The amide resulting from the formal condensation of 5-[(methylsulfonyl)amino]-1H-indole-2-carboxylic acid and 4-amino group of 1-[3-(isopropylamino)pyridin-2-yl]piperazine, delavirdine is a non-nucleoside reverse transcriptase inhibitor with activity specific for HIV-1. Viral resistance emerges rapidly when delavirdine is used alone, so it is therefore used (as the methanesulfonic acid salt) with other antiretrovirals for combination therapy of HIV infection.
- References
-
- cas:136817-59-9
- drugbank:DB00705
- drugcentral:799
- kegg.compound:C06941
- kegg.drug:D07782
- patent:WO9109849
- pdb-ccd:SPP
- pubmed:11124228
- pubmed:11225565
- pubmed:11327199
- pubmed:11363651
- pubmed:11363709
- pubmed:11364022
- pubmed:11364099
- pubmed:11364363
- pubmed:11364481
- pubmed:11590527
- pubmed:16449090
- pubmed:21080015
- pubmed:21683601
- pubmed:21865017
- reaxys:6356813
- wikipedia.en:Delavirdine
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
Phenotype
Phenotype resulting from delavirdine
Phenotype where environments contain delavirdine
Phenotype modified by environments containing delavirdine
Phenotype affecting delavirdine
Human Disease Model